Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SUV39H1-DNMT3A-mediated epigenetic regulation of Tim-3 and galectin-9 in the cervical cancer
Li Zhang, Sijuan Tian, Minyi Zhao, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
Yan Lv, Xiao Ma, Yuxin Ma, et al.
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2366-2382
Open Access | Times Cited: 70
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
An updated review on abnormal epigenetic modifications in the pathogenesis of systemic lupus erythematosus
Xingyu Zhou, Shengnan Zhou, Yaping Li
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Advances in epigenetic modifications and cervical cancer research
Hui Liu, Huimin Ma, Yang Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188894-188894
Open Access | Times Cited: 18
Chaetocin: A review of its anticancer potentials and mechanisms
Hangyu Jiang, Yuqi Li, Xiaocong Xiang, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174459-174459
Open Access | Times Cited: 33
High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies
Lavinia Ghiani, Susanna Chiocca
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3483-3483
Open Access | Times Cited: 24
The Role of Histone Modification in DNA Replication-Coupled Nucleosome Assembly and Cancer
Yaguang Zhang, Qin Zhang, Yang Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4939-4939
Open Access | Times Cited: 15
Epigenetic Perspective of Immunotherapy for Cancers
Sunita Keshari, Praveen Barrodia, Anand K. Singh
Cells (2023) Vol. 12, Iss. 3, pp. 365-365
Open Access | Times Cited: 12
DNA methyltransferase DNMT3A inhibits TP53AIP1 expression and promotes cervical cancer development and metastasis
Xiaohong Pan, Xiuluan Du, Shenshan Jia
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Targeting PARP for the optimal immunotherapy efficiency in gynecologic malignancies
Tianye Li, Xinrun Wang, Shuang Qin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114712-114712
Open Access | Times Cited: 10
Multifaceted roles of Galectins: from carbohydrate binding to targeted cancer therapy
Nan Zhang, Qiao Liu, Dan Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Epigenetic Therapy in Cervical Cancer
Anmi Jose, P. Shenoy, Yagya Malik, et al.
(2025), pp. 153-185
Closed Access
“Galectin-9: A double-edged sword in Acute Myeloid Leukemia”
Omolbanin Sargazi-Aval, Ali Mohammad Ahmadi, Ali Jihad Hemid Al-Athari, et al.
Annals of Hematology (2025)
Open Access
Targeted knockdown of Tim3 by short hairpin RNAs improves the function of anti-mesothelin CAR T cells
Leila Jafarzadeh, Elham Masoumi, Hamid Reza Mirzaei, et al.
Molecular Immunology (2021) Vol. 139, pp. 1-9
Open Access | Times Cited: 22
A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes
Huihui Xu, Huili Wang, Tong-Jin Xing, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Galectin-9 – ligand axis: an emerging therapeutic target for multiple myeloma
Rajib Shil, Norhan B. B. Mohammed, Charles J. Dimitroff
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2
Sarah Meister, Laura Hahn, Susanne Beyer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1880-1880
Open Access | Times Cited: 12
The role of epigenetic modifications in Colorectal Cancer Metastasis
Riya Su, Xinlin Wu, Tao Liang, et al.
Clinical & Experimental Metastasis (2022) Vol. 39, Iss. 4, pp. 521-539
Open Access | Times Cited: 12
Gene polymorphisms of LGALS2, LGALS3 and LGALS9 in patients with rheumatoid arthritis
Wang‐Dong Xu, Qian Wu, Yan‐Wei He, et al.
Cellular Immunology (2021) Vol. 368, pp. 104419-104419
Closed Access | Times Cited: 15
Epigenetic Changes and Functions in Pneumoconiosis
Yiping Li, Zhiwei Cheng, Hui Fan, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 11
Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model
Tahereh Soltantoyeh, Behnia Akbari, Zahra Shahosseini, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Niraparib enhances antitumor immunity and contributes to the efficacy of PD-L1 blockade in cervical cancer
Jie Chang, Shimin Quan, Sijuan Tian, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 1
SUV39H1 epigenetically modulates the MCPIP1-AURKA signaling axis to enhance neuroblastoma tumorigenesis
Mengzhen Li, Feifei Sun, Juan Wang, et al.
Oncogene (2024) Vol. 43, Iss. 45, pp. 3306-3320
Open Access | Times Cited: 1
Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications
Jihyun Moon, Yoo Min Oh, Sang‐Jun Ha
BMB Reports (2021) Vol. 54, Iss. 8, pp. 403-412
Open Access | Times Cited: 9
Decreased SUV39H1 at the promoter region leads to increased CREMα and accelerates autoimmune response in CD4+ T cells from patients with systemic lupus erythematosus
Shuang Luo, Huilin Zhang, Yuming Xie, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top